WuXi AppTec
WuXi AppTec offers Large-molecule bioanalysis, PK, immunogenicity and biomarkers. Services should be matched to the intended study and assay requirements.
Corporate information
- Company entity
- WuXi AppTec
- Headquarters / principal office
- Headquarters city not independently verified; see the country/network tags.
- Founded
- 2000 ↗
- Ownership / capital status
- Publicly tradedPublicly listed; see issuer disclosures ↗
- Official corporate reference
- https://wuxiapptec.com/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
The website describes a client case for a non-GLP-1 oral cyclic peptide, from library synthesis and lead optimization through GMP preparation. Only service capability is recorded; the unnamed client is neither identified nor guessed.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- 非 GLP-1 Oral Cyclic Peptides：先导优化至 GMP 案例
- Astellas and Cullgen collaboration
- WuXi AppTec history
- WuXi AppTec company page